Physician profile
Nancy R Barrett
NPI 1962403378
$666.48
in general payments reported to CMS, 2019-2025
19 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $46.36 · 2022: $81.79 · 2023: $172 · 2024: $120 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $82.84 | 2023-2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Olympus America INC. | $82.08 | 2022-2023 | Oes Choledochofiberscope, Olympus, 4k Camera Head |
| Davol INC. | $81.45 | 2020-2025 | Phasix Mesh |
| Smith+Nephew, INC. | $56.64 | 2023-2025 | Grafix, Stravix, Pico |
| Stryker Corporation | $46.50 | 2022-2025 | Molli |
| Medtronic, INC. | $43.85 | 2023-2025 | Dextile, Plasmablade(Tm) |
| Acera Surgical, INC. | $40.75 | 2019-2024 | Restrata Wound Matrix |
| Bard Peripheral Vascular, INC. | $34.59 | 2024 | Powerport M.R.I. Implantable Port |
| Teleflex LLC | $28.89 | 2019-2024 | Titan Sgs |
| Merck Sharp & Dohme LLC | $22.04 | 2025 | Keytruda |
| Shire North American Group INC | $21.73 | 2019 | |
| Innocoll Pharmaceuticals Limited | $20.73 | 2022 | |
| Glaxosmithkline, LLC. | $19.19 | 2024 | Trelegy Ellipta |
| Cook Medical LLC | $19.08 | 2019 | |
| Novo Nordisk INC | $17.30 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioptics, INC. | $12.91 | 2019 | |
| Boston Scientific Corporation | $12.74 | 2023 | Spyglass |
| Conmed Corporation | $12.05 | 2019 | |
| Endo Pharmaceuticals INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.